Trial record 1 of 2 for:
nkarta
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05020678 |
Recruitment Status :
Recruiting
First Posted : August 25, 2021
Last Update Posted : March 21, 2024
|
Sponsor:
Nkarta Inc.
Information provided by (Responsible Party):
Nkarta Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | August 2024 |
Estimated Study Completion Date : | December 2038 |